Drug intelligence / Profile preview

shRNA V0a2

Development stage
Unknown
Lead developer
Sigma Aldrich
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

shRNA V0a2 is an experimental short hairpin RNA (shRNA) construct designed to silence the expression of the a2 subunit of the vacuolar H+-ATPase (V-ATPase), which is encoded by the *ATP6V0A2* gene. The V-ATPase is a multi-subunit proton pump responsible for the acidification of intracellular compartments, including lysosomes and the Golgi apparatus. The a2 isoform (V0a2) is specifically localized to the Golgi and is frequently overexpressed in various malignancies, such as breast, ovarian, and prostate cancers. In these contexts, V0a2 contributes to the abnormal glycosylation of surface proteins and promotes an invasive phenotype by modulating the tumor microenvironment and intracellular trafficking. By utilizing RNA interference (RNAi), shRNA V0a2 achieves stable knockdown of the target protein, typically through delivery via lentiviral or adenoviral vectors. This tool is primarily used in preclinical research to investigate the role of pH regulation in oncogenesis and to evaluate the therapeutic potential of targeting the V-ATPase machinery to inhibit tumor cell invasion and growth.

Other names
ATP6V0A2 shRNAATP-6V0A2 shRNAATP 6V0A2 shRNAV-ATPase a2 shRNAV0a2 shRNAV-0a2 shRNAV 0a2 shRNAshRNA-mediated knockdown of V0a2
02

Targets

ATP6V0A2 (ATPase H+ transporting V0 subunit a2)

Beyond the preview

Go deeper on shRNA V0a2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shRNA V0a2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call